[Form 4] Hims & Hers Health, Inc. Insider Trading Activity
Hims & Hers Health, Inc. (HIMS) Chief Financial Officer Oluyemi Okupe sold 23,584 shares of Class A common stock on 09/22/2025 at an average weighted price of $57.7411 per share under a Rule 10b5-1 trading plan adopted May 21, 2025. Following the sale, the reporting person directly beneficially owns 105,400 shares and indirectly owns 7,853 shares held by the Oluyemi Okupe Separate Property Trust dated 9-1-2021. The filer certifies the sales were effected under the pre-established plan and offers to provide the exact breakdown of shares sold at each price within the reported $57.38–$58.245 range if requested by regulators or the issuer.
Il Direttore Amministrativo Finanziario di Hims & Hers Health, Inc. (HIMS), Oluyemi Okupe, ha venduto 23.584 azioni ordinarie di Classe A il 22/09/2025 a un prezzo medio ponderato di 57,7411 USD per azione, nell’ambito di un piano di trading Rule 10b5-1 adottato il 21 maggio 2025. A seguito della vendita, la persona che segnala detiene direttamente 105.400 azioni e indirettamente 7.853 azioni detenute dal Oluyemi Okupe Separate Property Trust datato 1-9-2021. Il dichiarante certifica che le vendite sono state effettuate nell’ambito del piano predefinito e si offre di fornire la ripartizione esatta delle azioni vendute a ciascun prezzo all’interno dell’intervallo riportato di 57,38–58,245 USD, se richiesto da regolatori o dall’emittente.
El Director Financiero de Hims & Hers Health, Inc. (HIMS), Oluyemi Okupe, vendió 23.584 acciones ordinarias de Clase A el 22/09/2025 a un precio medio ponderado de 57,7411 USD por acción, bajo un plan de negociación Rule 10b5-1 adoptado el 21 de mayo de 2025. Tras la venta, la persona informante posee directamente 105.400 acciones y posee indirectamente 7.853 acciones pertenecientes al Oluyemi Okupe Separate Property Trust con fecha de 1-9-2021. El presentante certifica que las ventas se realizaron bajo el plan preestablecido y se ofrece a proporcionar la distribución exacta de las acciones vendidas a cada precio dentro del rango informado de 57,38–58,245 USD, si lo solicitan reguladores o el emisor.
Hims & Hers Health, Inc. (HIMS)의 최고재무책임자 Oluyemi Okupe가 2025년 9월 22일 57.7411달러의 가중평균가로 23,584주를 매도하였으며, 이는 2025년 5월 21일에 채택된 Rule 10b5-1 거래 계획에 따른 것임으로 보도됩니다. 매도 후 보고자는 직접적으로 105,400주를 보유하고 있으며, 간접적으로는 2021년 9월 1일자 Oluyemi Okupe Separate Property Trust가 보유한 7,853주를 소유합니다. 제출자는 매매가 사전에 확정된 계획에 따라 이루어졌음을 인증하며, 규제기관이나 발행사가 요청할 경우 보고된 57.38–58.245 달러 구간 내 각 가격별 매도 주식의 정확한 분배를 제공하겠다고 밝힙니다.
Le directeur financier de Hims & Hers Health, Inc. (HIMS), Oluyemi Okupe, a vendu 23 584 actions ordinaires de classe A le 22/09/2025 à un prix moyen pondéré de 57,7411 USD par action dans le cadre d’un plan de trading Rule 10b5-1 adopté le 21 mai 2025. Suite à cette vente, la personne déclarante possède directement 105 400 actions et indirectement 7 853 actions détenues par le Oluyemi Okupe Separate Property Trust daté du 1er09-2021. Le déclarant certifie que les ventes ont été effectuées dans le cadre du plan préétabli et propose de fournir la répartition exacte des actions vendues à chaque prix dans la fourchette indiquée de 57,38–58,245 USD si cela est demandé par les régulateurs ou l’émetteur.
Der Chief Financial Officer von Hims & Hers Health, Inc. (HIMS), Oluyemi Okupe, verkaufte am 22.09.2025 23.584 Stammaktien der Klasse A zu einem gewichteten Durchschnittspreis von 57,7411 USD pro Aktie im Rahmen eines Rule-10b5-1-Handelsplans, der am 21.05.2025 angenommen wurde. Nach dem Verkauf besitzt die meldende Person direkt 105.400 Aktien und indirekt 7.853 Aktien, die vom Oluyemi Okupe Separate Property Trust mit Datum 01.09.2021 gehalten werden. Der Melder bestätigt, dass die Verkäufe gemäß dem vorher festgelegten Plan erfolgt sind, und bietet an, die genaue Aufschlüsselung der zu jedem Preis verkauften Aktien innerhalb des angegebenen Bereichs von 57,38–58,245 USD auf Anfrage von Regulierungsbehörden oder dem Emittenten bereitzustellen.
أدار المدير المالي لشركة Hims & Hers Health, Inc. (HIMS)، أولويومي أوكابي، بيع 23,584 سهماً من فئة A العادية في 22/09/2025 بسعر متوسط مرجح قدره 57.7411 دولار للسهم، وذلك في إطار خطة تداول Rule 10b5-1 التي تم اعتمادها في 21 مايو 2025. بعد البيع، أصبح الشخص المبلغ مباشرةً يملك 105,400 سهم وبشكل غير مباشر 7,853 سهمًا مملوكة للصندوق Oluyemi Okupe Separate Property Trust بتاريخ 01-09-2021. يصادق المبلغ على أن المبيعات تمت بموجب الخطة المسبقة، ويعرض تقديم التوزيع الدقيق لعدد الأسهم المباعة عند كل سعر ضمن النطاق المبلغ عنه 57.38–58.245 دولار إذا طُلب من الجهات التنظيمية أو المصدر.
Hims & Hers Health, Inc. (HIMS) 的首席财务官 Oluyemi Okupe 在 2025 年 9 月 22 日以每股加权平均价格 57.7411 美元，出售了 23,584 股 A 类普通股，依据于 2025 年 5 月 21 日通过的 Rule 10b5-1 交易计划。 交易后，申报人直接拥有 105,400 股，间接拥有由 2021 年 9 月 1 日设立的 Oluyemi Okupe Separate Property Trust 持有的 7,853 股。申报人确认这次出售是在预先设定的计划下进行，如监管机构或发行人要求，他愿意提供在报告的 57.38–58.245 美元区间内各价格的具体卖出股数分解。
- Sale executed under a Rule 10b5-1 trading plan, indicating pre-planned disposition rather than opportunistic insider timing
- Full disclosure of average weighted price and share ranges ($57.38–$58.245) and offer to provide breakdowns on request supports transparency
- Insider reduced direct holdings by 23,584 shares, which is a realized decrease in the CFO's stake
Insights
TL;DR: Insider sale under a 10b5-1 plan reduces holdings but appears pre-planned, so investor reaction likely muted.
The CFO executed a sale of 23,584 Class A shares at an average weighted price of $57.7411 under a Rule 10b5-1 plan adopted on May 21, 2025. The report shows the CFO still holds a meaningful direct stake of 105,400 shares plus 7,853 indirectly via a trust, which preserves ongoing alignment with shareholders. The presence of a 10b5-1 trading plan reduces the likelihood that this sale conveys new company-specific information, so the transaction is more compliance-driven than a signal about near-term fundamentals.
TL;DR: Proper disclosure and use of a 10b5-1 plan indicate governance procedures were followed.
The Form 4 discloses the relationship of the reporting person (Chief Financial Officer) and documents the Rule 10b5-1 plan adoption date, the average weighted sale price, and remaining beneficial ownership. The filing is signed by an attorney-in-fact and offers to provide detailed price-by-price sale information on request, reflecting attention to disclosure obligations. From a governance perspective, this filing meets standard transparency expectations for insider sales executed under trading plans.
Il Direttore Amministrativo Finanziario di Hims & Hers Health, Inc. (HIMS), Oluyemi Okupe, ha venduto 23.584 azioni ordinarie di Classe A il 22/09/2025 a un prezzo medio ponderato di 57,7411 USD per azione, nell’ambito di un piano di trading Rule 10b5-1 adottato il 21 maggio 2025. A seguito della vendita, la persona che segnala detiene direttamente 105.400 azioni e indirettamente 7.853 azioni detenute dal Oluyemi Okupe Separate Property Trust datato 1-9-2021. Il dichiarante certifica che le vendite sono state effettuate nell’ambito del piano predefinito e si offre di fornire la ripartizione esatta delle azioni vendute a ciascun prezzo all’interno dell’intervallo riportato di 57,38–58,245 USD, se richiesto da regolatori o dall’emittente.
El Director Financiero de Hims & Hers Health, Inc. (HIMS), Oluyemi Okupe, vendió 23.584 acciones ordinarias de Clase A el 22/09/2025 a un precio medio ponderado de 57,7411 USD por acción, bajo un plan de negociación Rule 10b5-1 adoptado el 21 de mayo de 2025. Tras la venta, la persona informante posee directamente 105.400 acciones y posee indirectamente 7.853 acciones pertenecientes al Oluyemi Okupe Separate Property Trust con fecha de 1-9-2021. El presentante certifica que las ventas se realizaron bajo el plan preestablecido y se ofrece a proporcionar la distribución exacta de las acciones vendidas a cada precio dentro del rango informado de 57,38–58,245 USD, si lo solicitan reguladores o el emisor.
Hims & Hers Health, Inc. (HIMS)의 최고재무책임자 Oluyemi Okupe가 2025년 9월 22일 57.7411달러의 가중평균가로 23,584주를 매도하였으며, 이는 2025년 5월 21일에 채택된 Rule 10b5-1 거래 계획에 따른 것임으로 보도됩니다. 매도 후 보고자는 직접적으로 105,400주를 보유하고 있으며, 간접적으로는 2021년 9월 1일자 Oluyemi Okupe Separate Property Trust가 보유한 7,853주를 소유합니다. 제출자는 매매가 사전에 확정된 계획에 따라 이루어졌음을 인증하며, 규제기관이나 발행사가 요청할 경우 보고된 57.38–58.245 달러 구간 내 각 가격별 매도 주식의 정확한 분배를 제공하겠다고 밝힙니다.
Le directeur financier de Hims & Hers Health, Inc. (HIMS), Oluyemi Okupe, a vendu 23 584 actions ordinaires de classe A le 22/09/2025 à un prix moyen pondéré de 57,7411 USD par action dans le cadre d’un plan de trading Rule 10b5-1 adopté le 21 mai 2025. Suite à cette vente, la personne déclarante possède directement 105 400 actions et indirectement 7 853 actions détenues par le Oluyemi Okupe Separate Property Trust daté du 1er09-2021. Le déclarant certifie que les ventes ont été effectuées dans le cadre du plan préétabli et propose de fournir la répartition exacte des actions vendues à chaque prix dans la fourchette indiquée de 57,38–58,245 USD si cela est demandé par les régulateurs ou l’émetteur.
Der Chief Financial Officer von Hims & Hers Health, Inc. (HIMS), Oluyemi Okupe, verkaufte am 22.09.2025 23.584 Stammaktien der Klasse A zu einem gewichteten Durchschnittspreis von 57,7411 USD pro Aktie im Rahmen eines Rule-10b5-1-Handelsplans, der am 21.05.2025 angenommen wurde. Nach dem Verkauf besitzt die meldende Person direkt 105.400 Aktien und indirekt 7.853 Aktien, die vom Oluyemi Okupe Separate Property Trust mit Datum 01.09.2021 gehalten werden. Der Melder bestätigt, dass die Verkäufe gemäß dem vorher festgelegten Plan erfolgt sind, und bietet an, die genaue Aufschlüsselung der zu jedem Preis verkauften Aktien innerhalb des angegebenen Bereichs von 57,38–58,245 USD auf Anfrage von Regulierungsbehörden oder dem Emittenten bereitzustellen.
FAQ
What insider transaction did HIMS CFO Oluyemi Okupe report on Form 4?
How many HIMS shares does the reporting person own after the sale?
Was the sale pre-planned or discretionary?
What price range were the shares sold at in the HIMS Form 4?
Who signed the Form 4 filing for Oluyemi Okupe?
